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RESEARCH ARTICLE
A balance of positive and negative
regulators determines the pace of the
segmentation clock
Guy Wiedermann1†, Robert Alexander Bone1†, Joana Clara Silva1, Mia Bjorklund1,
Philip J Murray2‡, J Kim Dale1*‡
1Division of Cell and Developmental Biology, College of Life Sciences, University of
Dundee, Dundee, United Kingdom; 2Division of Mathematics, University of Dundee,
Dundee, United Kingdom
Abstract Somitogenesis is regulated by a molecular oscillator that drives dynamic gene
expression within the pre-somitic mesoderm. Previous mathematical models of the somitogenesis
clock that invoke the mechanism of delayed negative feedback predict that its oscillation period
depends on the sum of delays inherent to negative-feedback loops and inhibitor half-lives. We
develop a mathematical model that explores the possibility that positive feedback also plays a role in
determining the period of clock oscillations. The model predicts that increasing the half-life of the
positive regulator, Notch intracellular domain (NICD), can lead to elevated NICD levels and an
increase in the oscillation period. To test this hypothesis, we investigate a phenotype induced by
various small molecule inhibitors in which the clock is slowed. We observe elevated levels and
a prolonged half-life of NICD. Reducing NICD production rescues these effects. These data provide
the first indication that tight control of the turnover of positive as well as negative regulators of the
clock determines its periodicity.
DOI: 10.7554/eLife.05842.001
Introduction
The formation of the vertebrate skeleton and associated musculature relies on the ordered and timely
segmentation of mesodermal tissue during early embryonic development. Segmentation is progressive
and occurs in an anterior to posterior direction as the body axis elongates (reviewed in Oates et al.,
2012). Mesodermal segments, or somites, ‘pinch off’ at the rostral limit of the two rods of pre-somitic
mesoderm (PSM) that lie on either side of the caudal neural tube, with a distinct, species-specific
periodicity; every 90 min in the chicken and every 120 min in the mouse. This periodicity is regulated by
a molecular oscillator, known as the segmentation clock, that is defined by cyclic gene expression within
PSM tissue with a period that regulates somite formation. These ‘clock’ genes belong to the Notch,
WNT and FGF signalling pathways and are expressed in a cyclical pattern in the PSM of a wide variety
of vertebrate species (Krol et al., 2011; reviewed in Deque´ant et al., 2008; Gibb et al., 2010;
Maroto et al., 2012). On a single cell level in the vertebrate PSM, oscillatory gene expression is
believed to be established through negative feedback loops of unstable clock gene products.
Previous mathematical models of the somitogenesis clock that invoke the mechanism of delayed
negative feedback predict that the clock period can be approximated as a sum of the delays involved in
processes such as transcription, splicing, translation and transport and the half-lives of inhibitors of clock
gene expression (Lewis, 2003; Monk, 2003; Ay et al., 2013; Hanisch et al., 2013). Subsequent studies
have confirmed that the period can be altered by genetically modifying genes that encode negative
regulators (e.g., Hes7, Her6, Her7, Nrarp) (Herrgen et al., 2010; Schro¨ter and Oates, 2010; Kim et al.,
2011; Takashima et al., 2011;Oates et al., 2012; Harima, et al., 2013;Hoyle and Ish-Horowicz, 2013).
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Moreover, it has been shown that regulation of clock gene mRNA turnover and degradation is gene
specific and regulated at the level of the 3′UTR (Hilgers et al., 2005; Nitanda et al., 2014). In contrast,
there has been relatively little experimental work demonstrating the predicted role of protein stability in
regulating the periodicity of clock gene oscillations (Hirata et al., 2004).
It is notable that models that invoke delayed negative feedback as the mechanism underlying the
somitogenesis clock were developed primarily from zebrafish data, where the clock period is relatively
short and there are significantly fewer oscillating components than other vertebrate species (Krol
et al., 2011). Moreover, in zebrafish there is experimental evidence that Notch plays a key role in the
synchronisation of neighbouring oscillators (Delaune et al., 2012) but that it is not necessary for
oscillations themselves (Ozbudak and Lewis, 2008). In contrast, Notch signalling in mouse and chick
is thought to be essential for oscillations (Ferjentsik et al., 2009). One crucial factor in this regard is
the Notch1 intracellular domain (NICD) which is cleaved following ligand activation, translocates to
the nucleus and activates Notch target gene expression. NICD is unstable and, at least in mouse, its
production appears as pulsatile, spatio-temporal waves that traverse the rostro-caudal axis of the PSM
in the manner of a clock gene (Huppert et al., 2005). Importantly, pulsatile Notch1 protein expression
was recently shown to be dependent on Notch signalling in the PSM of both chick and mouse (Bone
et al., 2014); this raises the possibility that, in mouse and chick at least, positive feedback, mediated
by Notch and NICD, plays a role in the clock mechanism.
In this study we develop a mathematical model of the clock that describes both repression and
NICD-mediated activation of clock gene transcription. The model predicts that increasing the half-life
of NICD results in elevated levels of NICD and a longer clock period. Notably, these effects are not
observed in the model upon increasing the half-life of the repressing clock protein. To test the
eLife digest During embryo development, animals with backbones (also called vertebrates)
repeatedly lay down pairs of segments along the axis that runs from the head to the tail of the
embryo. These segments, known as somites, eventually form part of the skeleton, as well as the
associated muscle, cartilage, tendons and some skin. Importantly, the segments in some species take
longer to form than those in other species, and they also form in proportion to the overall size of the
animal.
A ‘segmentation clock’ regulates the timing of somite formation via cycles in which genes are
repeatedly switched on and then off again. Some aspects of this process are well understood. Firstly,
many ‘clock genes’ are known to produce proteins that can inhibit their own production. However,
this ‘negative feedback’ is typically delayed because it takes time to produce and transport protein
within a cell. The inhibitory proteins are also unstable and their breakdown leads to an end of their
inhibitiory effect. It is also known that: some proteins send signals to neighbouring cells while others,
including one called Notch, receive them; and the received signals activate the expression of clock
genes. However, until now, no one had studied how the turnover (that is, the production and
breakdown) of the proteins that activate clock gene expression could regulate the pace of the clock.
Wiedermann, Bone et al. used a two-pronged approach to investigate this question. First, they
developed a computational model that accounted for both inhibition and activation of clock gene
expression. The model predicts that the clock slows down when the levels of a positive regulator
called Notch intracellular domain (or NICD for short) are high. This is because the negative regulators
would have to overcome the increased positive regulators to switch off the clock genes. A slower
segmentation clock would be expected to give rise to fewer, larger somites in a given length of time
when compared to a similar clock with a faster pace.
To test these predictions, Wiedermann, Bone et al. next conducted experiments on chicken
embryos, which are commonly used in studies of animal development. The experiments agreed with
the model predictions. That is, when treated with a variety of drugs that affected NICD turnover and
thereby increased the levels of NICD, the clock slowed and these chicken embryos developed fewer,
but larger somites. As predicted by the mathematical model, these effects were rescued when
Wiedermann, Bone et al. reduced the production of NICD. These findings show that a balance of
positive and negative regulators determines the pace of the segmentation clock.
DOI: 10.7554/eLife.05842.002
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predictions, we use a pharmacological approach that robustly delays the phase patterns of a clock
gene in the chick and mouse PSM. Under these conditions, using a custom made antibody that
recognises endogenous chick NICD, we show that, concomitant to delaying the pace of oscillations,
the inhibitors increase both levels of NICD and its half-life. In agreement with model predictions, we
rescue the phase patterns of clock gene expression by reducing NICD production. These data
therefore suggest that increasing the half-life of NICD and thus increasing its turnover time increases
the period of the somitogenesis clock.
Results
Mathematical modelling predicts that increased NICD half-life results in
higher levels of NICD and a longer clock period
In order to investigate the role of both positive and negative feedback in the circuitry of the
somitogenesis clock, we developed a mathematical model in which the key regulatory interactions are
that an inhibitory clock protein and NICD negatively and positively regulate gene transcription,
respectively (see ‘Materials and methods’ and Figure 1A,B). Hence in the absence of clock protein but
presence of NICD, transcription occurs. Conversely, transcription is inhibited when there are high
levels of inhibitor and low levels of activator.
In Figure 1C we plot a representative numerical solution of the model. In a given cycle of the clock,
NICD activates transcription, resulting in the production of cytoplasmic protein after some delay, T1.
Clock protein then represses transcription and after a further delay, T2 , NICD is produced and
activates the next cycle of the clock. In the model, perturbing protein half-lives alters the balance
between activation and repression in a manner that modifies the clock period. In Figure 1D we show
that increasing the NICD half-life increases the period of the oscillation and the levels of both NICD
and clock protein. In Figure 1E we show that increasing the clock protein half-life does not greatly
affect the oscillator period but reduces levels of NICD.
In order to further explore model behaviour we calculated solutions of the model in different
regions of parameter space. In Figure 1F,G we show that the oscillator period and levels of NICD
increase with NICD half-life but that these effects are not seen upon increasing the clock protein
half-life. In Figure 1H we show that the increased period, arising as a consequence of increased
NICD half-life, can be rescued by reducing the NICD production rate. These numerical solutions
demonstrate that, in the model, the balance between NICD production and degradation rates plays
a key role in determining the clock period. Additionally, we note that there is a critical value of the
production rate below which the trivial steady-state becomes stable (solutions tend to zero) and
that perturbing clock protein and NICD production and decay rates can drive the system into stable
states (e.g., by increasing repressor half-life in Figure 1F or reducing the NICD production rate in
Figure 1H).
Wnt inhibition delays the pace of cLfng oscillations in the chick and
mouse PSM
It has previously been reported that modulating either the Shh or Wnt pathways can affect the pace of
clock gene oscillations in the PSM (Gibb et al., 2009; Resende et al., 2010; Gonzalez et al., 2013).
To experimentally test the predictions of our model, we used a half-embryo assay to investigate whether
levels and half-life of NICD were elevated under conditions where clock gene oscillations were robustly
delayed using a pharmacological approach (see ‘Materials and methods’; Gibb et al., 2009). In the first
instance, PSM explants from chick embryos between Hamburger Hamilton (HH) stages 10–12 were
exposed to XAV939, a specific Wnt inhibitor that acts by inhibiting Tankyrase1 (TNK1) and TNK2
enzymes, which normally degrade Axin2. Hence upon treatment with XAV939, AXIN2 protein is
stabilised and maintains phosphorylated β-catenin protein in the destruction complex (Huang et al.,
2009).
Following a titration assay, we determined that 100 μM XAV939 treatment was the lowest
concentration that caused robust and reproducible down regulation of the Wnt target genes
cAxin2 and cLef1 compared to the corresponding DMSO-treated contralateral explants
(Figure 2—figure supplement 1C,D; n = 61/68; Bone et al., 2014) and led to increased levels
of phosphorylated β-catenin at Ser33, Ser37, Thr41, as expected (Figure 2—figure supplement 1A;
n = 8/10). Using the same assay, we investigated the effect of the inhibitor on the dynamic
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Figure 1. A mathematical model of positive and negative regulation of the somitogenesis clock. (A) A schematic illustration of inter-cellular coupling via
Delta-Notch signalling. (B) A schematic illustration of the reduced model in which the pulsatile production of NICD is down stream of clock gene
expression. (C–E) Representative numerical solution of the model Equations (1)-(3). Clock protein (p(t), solid line) and NICD (n(t), dashed line) levels are
plotted against time. (C) ’Wild-type’ oscillations (k_4 = 0.063), (D) Decreasing NICD decay rate yields longer period oscillations (k_4 = 0.023),
(E) Decreasing Hes7 decay rate lowers levels of Hes7 and NICD (k_2 = 0.035). (F) The oscillation period (colour) is plotted against Hes7 and NICD half-lives.
(G) NICD level is plotted against Hes7 and NICD half-lives. (H) Oscillator period is plotted against NICD production rate and half-life. (E–G) Solid lines
Figure 1. continued on next page
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expression of cLfng in the PSM. Following exposure to 100 μM XAV939, the domain of cLfng
expression was at least 1 phase behind that of the control explant (Figure 2A, M; n = 57/64) and
occasionally this resulted in the treated explant forming one less somite boundary than the control
explant. These data imply that 100 μM XAV939 treatment noticeably lengthens the period of the
oscillations. In explant pairs where both sides were DMSO-treated, an asymmetric pattern of cLfng
expression was rarely seen (n = 2/18, data not shown) and, as such, the effects of XAV939 on cLfng
expression could not be attributed to DMSO, natural variability in expression, or to the assay itself.
In order to ensure that the oscillations were delayed and not halted, a fix and culture assay (see
‘Materials and methods’) revealed that cLfng expression was still dynamic in the presence of 100 μM
XAV939 (Figure 2B; n = 8/9). Furthermore, Phospho-histone H3 (pH3) and NucView analyses
demonstrated that neither proliferation nor apoptosis, respectively, were significantly affected
following drug treatment (Figure 2—figure supplement 2A,D; n = 4, p = 0.236; n = 4, p = 0.292).
These data clearly demonstrate that Wnt inhibition delays the period of the segmentation clock in
the chick PSM. Using the same half-embryo inhibitor assay in the mouse embryo, we found that
exposure to 100 μM XAV939 delayed the pace of mLfng oscillations as compared to control DMSO-
treated E10.5 half PSM explants (Figure 2I; n = 19/26). Moreover, a fix and culture assay revealed
that mLfng expression was still dynamic in the presence of 100 μM XAV939 (Figure 2J; n = 12/20).
Shh inhibition does not delay the pace of cLfng oscillations in the
chick PSM
Similarly, we directly perturbed the Shh pathway in the half-embryo assay using Cyclopamine,
a well-established inhibitor of Shh signalling. At 25 μM, Cyclopamine abolished expression of
the Shh target gene cGli1 in the chicken half-PSM explant compared to the DMSO control
(Figure 3A; n = 5/5). Surprisingly, and in contrast to published data (Resende et al., 2010),
cLfng expression in the PSM was not delayed at either 25 μM (Figure 3B,D; n = 6/9) or 50 μM
(Figure 3C,D; n = 3/4). This assay suggests that Shh signalling does not play a direct role in the
regulation of the segmentation clock.
Exposure to XAV939 increases the level of cNICD in the chick and
mouse PSM
Given our results with the Wnt inhibitor and that NICD stability is known, in other contexts, to be
regulated by GSK3B (Espinosa et al., 2003; Jin et al., 2009; see also Foltz et al., 2002), we
investigated whether the effect upon the period was associated with a change in levels of NICD, as the
model predicted. To that end we generated a polyclonal anti-cNICD antibody raised against the
chicken N-terminal sequence of the cleaved chicken Notch1 intracellular domain. The epitope is only
exposed after gamma secretase cleavage and is not accessible in the un-cleaved form. After
confirming specificity by Western Blotting against recombinant cNICD protein (Figure 4A, lanes 1, 2),
we cultured half-PSM explant pairs in the presence of the γ-secretase inhibitor LY411575 (Lanz et al.,
2004) or DMSO for 3 hr. Western Blot revealed a specific band against endogenous cNICD that ran at
the same size as recombinant cNICD protein and at the predicted molecular weight of ∼87 kDa in
the DMSO control pool which was abolished in the +LY411575 treated pool, thereby validating
the specificity of the antibody (Figure 4A, lanes 3, 4; Figure 4D, lanes 1, 2). We performed
immunohistochemistry on sagittal sections of chick PSM tissue to analyse the spatial localisation
profile of NICD in this tissue and found it to exhibit a very similar profile to that described for mNICD
in the mouse PSM (Huppert et al., 2005). Thus cNICD is produced in (and cleared from) discrete
domains of the PSM in a manner reminiscent of the expression profile of clock genes in different
phases of the cycle (Figure 4B).
Figure 1. Continued
depict emergence of the non-trivial steady-state. Dashed lines depict points in parameter space where the nontrivial steady state undergoes a Hopf
bifurcation. Damped Oscillations (DO), Stable Oscillations (SO), No Oscillations (NO). Unless otherwise stated, parameter values are: k1=123 min−1,
k2=0.058 min−1, k3=134 min−1, k4=0.063 min−1, T1=44.0 min, T2=67.0 min, KP=125, KN=125.
DOI: 10.7554/eLife.05842.003
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Figure 2. XAV939, Roscovitine, DRB and PHA767491 treatment delays the pace of the segmentation clock in the chick and mouse PSM. Bissected chick
or mouse caudal explant pairs treated ‘−’ or ‘+’ inhibitor (A, C, E, G) or treated with inhibitor and subjected to the fix and culture assay (B, D, F, H) and
then analysed by in situ hybridisation for Lfng mRNA expression : (A, C, E, G) Treatment of chick PSM explants in the presence (+) or absence (−) of
XAV939 (A), Roscovitine (C), DRB (E) and PHA7667491 (G) for 3 hr reveals that ‘+’ explants have lagging expression of cLfng, often with one less somite
Figure 2. continued on next page
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To investigate if exposure to XAV939 affects the levels of endogenous cNICD, chick embryos were
bissected as before and contralateral sides pooled. For each reagent, one pool was cultured for 3 hr in
DMSO and the other was cultured in the inhibitor. In order to cease production of new NICD, both
control and inhibitor treated pools were cultured for an additional hour in the presence of
cycloheximide (Figure 4C). Lysates were then analysed by Western Blot for NICD. Strikingly, we
observed that the level of cNICD protein was increased significantly in the presence of XAV939
(Figure 4D, lanes 5, 6; n = 7/9; Table 1) compared to the corresponding DMSO control pool where
the resident cNICD had degraded substantially in the presence of cycloheximide. For each assay,
additional control explants confirmed that: i) Lfng was delayed in inhibitor treated explants; and ii)
samples cultured for 3 hr in the absence of inhibitor and then for the last hour in cycloheximide alone
showed a reduction in levels of NICD when compared to contralateral explants cultured in Ethanol for
the last hour (Figure 4D, lanes 3, 4). Notably, even in the absence of cycloheximide (Figure 4—figure
supplement 1A), levels of cNICD in the chicken PSM were consistently higher when treated with
XAV939 (Figure 4—figure supplement 1B; n = 5/5; Table 1) compared to respective DMSO control
lysates, although the mean fold-change increase was slightly less. These assays reveal that exposure to
XAV939 elevates the level of cNICD protein in the chicken PSM, just as it delays oscillations of the
Notch target gene cLfng. Significantly, exposure to Cyclopamine did not affect the levels of
cNICD in treated PSM explants just as it did not affect the pace of cLfng oscillations in this tissue
(Figure 4D, lanes 13, 14; n = 2/2; Table 1).
Given the consistent effect of 100 μM XAV939 upon both cLfng andmLfng oscillations, we used the
same assay to investigate whether this reagent also affected levels of mNICD in the mouse PSM, with
the initial culture period extended to 4 hr to allow for the longer clock period in the mouse embryo.
Strikingly, we observed that the level of mNICD protein in the PSM was increased significantly in the
presence of XAV939 (Figure 4E, lanes 3, 4; n = 8) compared to the corresponding DMSO control pool
of half PSM explants, where mNICD levels had dropped substantially in the presence of cycloheximide
(Figure 4E, lanes 1, 2; Table 1). Thus, the effect of XAV939 to delay the pace of Lfng oscillations
across the PSM and to increase the level of NICD in the PSM is conserved in both chick and mouse.
Cyclin dependent kinase inhibitors delay the pace of Lfng oscillations in
the PSM
Previous studies have shown that the stability of NICD in other contexts can be regulated by cyclin
dependent kinase (CDK) mediated phosphorylation (Fryer et al., 2004). Given the prediction of the
mathematical model that modification of NICD stability can influence the period of the clock, we
investigated whether perturbing CDK signalling would affect either clock gene oscillations and/or
levels of NICD in the chick PSM. To that end, we directly perturbed the CDK pathway in the half-
embryo assay using the CDK inhibitor Roscovitine. Roscovitine is a 2,6,9-substituted purine analogue
that competes with ATP for the active binding site on CDKs (MacCallum et al., 2005).
Figure 2. Continued
formed than the ‘−’ explants. (B, D, F, H): After 3 hr treatment in the presence of XAV393 (B), Roscovitine (D), DRB (F) and PHA767491 (H), one chick PSM
explant was fixed while the other was treated for another 45 min, showing that cLfng expression is still dynamic in the presence of these inhibitors.
(I, K): Mouse PSM explants treated in the presence or absence of XAV939 (I) or Roscovitine (K) for 4 hr revealed a delay in the oscillations of mLfng
expression. (J, L): Treatment of one mouse PSM explant for 4 hr, and the other for 5 hr in the presence of XAV939 (J) or Roscovitine (L) reveals that mLfng
mRNA expression is still oscillating in the PSM. The red arrowheads identify the somites that have formed during the in vitro culture period of the assay.
(M) Schematic representation of the expression domains of Lfng in the PSM in the three different phases of one oscillation cycle. S1, SII = the most
recently formed somite. (P) = previous cycle.
DOI: 10.7554/eLife.05842.004
The following figure supplements are available for figure 2:
Figure supplement 1. XAV939, Roscovitine, DRB treatment down-regulates expression of the Wnt target Axin2 and the Shh target Gli1 in the chick PSM.
DOI: 10.7554/eLife.05842.005
Figure supplement 2. XAV939, Roscovitine, DRB treatment does not induce apoptosis or affect cell proliferation in the chick PSM.
DOI: 10.7554/eLife.05842.006
Figure supplement 3. XAV939, Roscovitine, DRB and PHA-767491 treatment delays dynamic mRNA expression of Notch target clock genes in the chick
PSM thereby extending the clock period.
DOI: 10.7554/eLife.05842.007
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We found that Roscovitine treatment at 10 μM clearly delayed oscillation of cLfng expression
relative to the DMSO control (Figure 2C; n = 59/62) whilst the fix and culture assay confirmed that
cLfng expression was still oscillatory (Figure 2D; n = 8/10). Neither proliferation (Figure 2—figure
supplement 2B; n = 5, p = 0.204) nor apoptosis (Figure 2—figure supplement 2E; n = 4, p = 0.886)
were significantly affected in the PSM. However, exposure to 100 or 300 μM Roscovitine severely
impacted both proliferation and apoptosis and strongly down-regulated or abolished cLfng
expression (data not shown). These findings reveal that the oscillations of cLfng expression in the
chicken PSM are slowed by Roscovitine treatment at a concentration that does not appear to
affect cell proliferation. Moreover, we found that exposure to 10 μM Roscovitine delayed the
pace of mLfng oscillations as compared to control DMSO-treated E10.5 mouse half PSM
explants (Figure 2K; n = 20/22). The fix and culture assay revealed that mLfng expression was
still dynamic in the presence of 10 μM Roscovitine (Figure 2L; n = 8/10).
Roscovitine is a broad spectrum CDK inhibitor. We used an additional two CDK inhibitors reported
to specifically reduce the kinase activities of CDK7/CyclinH and CDK9/CyclinT towards the C-terminal
domain (CTD) of RNA pol II: 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB; a nucleoside
analogue) and PHA-767491. We found that exposure of chick half-PSM explants to 10 μM DRB
delayed cLfng oscillation phase compared to the control explant (Figure 2E; n = 67/73) and the fix
and culture assay confirmed that cLfng expression was still oscillatory in the PSM at this concentration
(Figure 2F; n = 15/18). Western Blotting analysis confirmed that phosphorylation of Serine 5 on the
CTD of RNA pol II was reduced by 10 μM DRB treatment (Figure 2—figure supplement 1B; n = 3/3;
mean fold change = 0.709). Neither proliferation (Figure 2—figure supplement 2C; n = 5, p = 0.884)
nor apoptosis (Figure 2—figure supplement 2F; n = 3, p = 0.844) were significantly affected.
Similarly, exposure to 1 μM PHA-767491 reduced phosphorylation of Serine 5 on the CTD of RNA pol
II (Figure 2—figure supplement 1B; n = 2; mean fold change = 0.709), delayed cLfng oscillation
phase compared to the control half-PSM (Figure 2G; n = 13) and the fix and culture assay confirmed
that cLfng expression was still oscillatory in the PSM at this concentration (Figure 2H; n = 6). Another
cycling Notch target, cHairy2, was also consistently delayed compared to the respective DMSO
control when treated with either XAV939 (Figure 2—figure supplement 3A; n = 4/6), Roscovitine
Figure 3. Cyclopamine treatment does not affect the pace of cLfng oscillations in the chick PSM. Bissected chick caudal explant pairs treated ‘−’or ‘+’
cyclopamine and then analysed by in situ hybridisation for Lfng or Gli1mRNA expression. (A): At 25 μM, cyclopamine inhibits expression of the Shh target
gene cGli1 in the chick PSM after 3 hr treatment. (B, C): The expression domains and intensity of cLfng mRNA are the same in the PSM of the ‘−’ or ‘+’
cyclopamine halves of each embryo and there is no difference in the number of somites in each half of a pair thus we conclude the pace of Lfng oscillation
is not affected by cyclopamine treatment for 3 hr at either 25 μM (B) or 50 μM (C). (D) Schematic representation of the expression domains of Lfng in the
PSM in the three different phases of one oscillation cycle. S1, SII = the most recently formed somite.
DOI: 10.7554/eLife.05842.008
Wiedermann et al. eLife 2015;4:e05842. DOI: 10.7554/eLife.05842 8 of 28
Research article Computational and systems biology | Developmental biology and stem cells
Figure 4. cNICD levels in the chick PSM are elevated after exposure to XAV939, Roscovitine, DRB or PHA767491.
(A): A polyclonal cNICD antibody was raised against the N-term sequence of the cleaved chicken Notch1
intracellular domain. The epitope is only exposed after gamma secretase cleavage and is not accessible in the
uncleaved form. By Western Blot analysis the antibody detects a band of protein at around 90KDa (see arrow) in an
in vitro-generated recombinant cNICD sample, which is not detected in the control IVT sample; this band
Figure 4. continued on next page
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(Figure 2—figure supplement 3B; n = 6/7), DRB (Figure 2—figure supplement 3C; n = 5/6) or PHA-
767491 (n = 8/8; Figure 2—figure supplement 3D). These data demonstrate that a panel of CDK
inhibitors robustly delays Notch target clock gene oscillations in the PSM in a similar way to that seen
following Wnt inhibition and that these effects are separable from the cell cycle.
The CDK inhibitors do not appear to affect clock period via inhibition of
canonical Wnt signalling
In order to investigate whether the CDK inhibitors all act through the Wnt pathway to elicit their effect
on the clock period, we assayed transcription of the Wnt target cAxin2 in the caudal chicken PSM. We
found that 100 μM XAV939 (Figure 2—figure supplement 1D), 10 μM Roscovitine (Figure 2—figure
supplement 1E; n = 31/41) and 10 μM DRB (Figure 2—figure supplement 1F; n = 29/42) robustly
down-regulated transcription of cAxin2 in the caudal chicken PSM, compared to the DMSO control.
These data raise the possibility that the effects of these reagents on the segmentation clock are via
inhibition of Wnt activity. However, the increased phosphorylation of β-catenin at Ser33, Ser37, Thr41
observed with XAV939, which serves as a readout of Wnt inhibition, was not observed following
exposure to 10 μM Roscovitine (Figure 2—figure supplement 1A; n = 5/6) or 10 μM DRB
(Figure 2—figure supplement 1A; n = 4/4), suggesting that the mechanism by which these CDK
inhibitors inhibit transcription of cAxin2 is not through the inhibition of canonical Wnt signalling.
However, alternative mechanisms of Wnt inhibition exist that do not lead to an increase in β-catenin
phosphorylation and thus we cannot rule out an effect of CDK inhibition via changes in Wnt signalling.
Exposure to cyclin dependent kinase inhibitors increases the level of
cNICD in the PSM
Having shown that Wnt inhibition or exposure to a panel of CDK inhibitors robustly delays the pace of
the segmentation clock, a key question is whether or not there is a common mechanism underlying
these observations. We thus investigated whether levels of NICD were perturbed by the CDK inhibitor
treatments. Using the same assay as described above, one pool of PSMs was cultured for 3 hr in
DMSO and the contralateral halves were cultured in the inhibitor. Both pools were then cultured for an
hour in the presence of cycloheximide before Western Blot analysis (Figure 4C). Remarkably, and in
agreement with model predictions, we observed that the level of cNICD protein was again
increased significantly in the presence of Roscovitine (Figure 4D, lanes 7, 8; n = 9/10), DRB
Figure 4. Continued
disappears in half chick PSM pools (see ‘Materials and methods’) after 3 hr treatment with 150 nM LY411575, a
concentration shown previously to have no toxic effects to PSM tissue (Bone et al., 2014). (B): Immunohisto-
chemistry for cNICD protein on 16 μm sagittal sections of sucrose agar embedded HH10 chicken embryo tails
showing dynamic phases of localisation in the PSM and schematic representations to the right of each panel. S1 - S3
= somite; S0 - S-1 = prospective somite region of anterior PSM. (C): A schematic illustrating the cNICD degradation
assay: corresponding pools of 9 PSM explants are incubated in the presence or absence of an inhibitor for 3 (chick)
or 4 hr (mouse), before treating all pools with the protein synthesis inhibitor cycloheximide (CHX) for a further hour.
Lysates are then collected for Western Blot analysis. (D): Representative Western Blot showing levels of cNICD
protein in lysates of chick PSM pools are increased after treatment with XAV939, Roscovitine, DRB and PHA767491,
but not with cyclopamine. Lanes 1 and 2 show exposure to 150 nM LY411575 alone for 3 hr removes all NICD and
serves as a control for the western. Lanes 3 and 4 show exposure to CHX alone in the last hour of culture severely
depletes NICD levels as compared to NICD levels in the pool of contralateral PSM explants cultured in DMSO.
(E): Levels of mNICD in the mouse PSM pools are increased following treatment with XAV939. Lanes 1 and 2 show
that NICD protein levels drop drastically after exposure for 1h to CHX as compared to strong NICD signal in lysate
from the contralateral half PSMs treated with EtOH. (F): Representative Western Blot showing levels of cNICD
protein in lysates of chick PSM pools are increased after treatment with XAV939, Roscovitine and DRB when
LY411575 is added to the culture for the last hour (in place of CHX). Lanes 1 and 2 show exposure to LY411575 alone
only in the last hour severely depletes NICD levels as compared to the NICD levels in the pool of contralateral PSM
explants cultured in DMSO.
DOI: 10.7554/eLife.05842.009
The following figure supplement is available for figure 4:
Figure supplement 1. XAV939, Roscovitine, and DRB treatment increases the level of cNICD in the chick PSM.
DOI: 10.7554/eLife.05842.010
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(Figure 4D, lanes 9, 10; n = 6/8) and PHA-767491 (Figure 4D, lanes 11, 12; n = 2/2) compared to
the corresponding DMSO control pool (See Table 1). Again, even in the absence of cycloheximide
(Figure 4—figure supplement 1A), levels of cNICD in the chicken PSM were consistently higher when
treated with Roscovitine (Figure 4—figure supplement 1C; n = 5/7), and DRB (Figure 4—figure
supplement 1D; n = 4/6) compared to respective DMSO control lysates (See Table 1). Thus, Roscovitine,
DRB and PHA-767491 treatments all increase the level of cNICD protein in the chicken PSM, just as
they all delay oscillations of the Notch target gene cLfng. Hence, taken together the data with the
Wnt and CDK inhibitors fulfil the predictions of the model that increased levels of NICD will be
associated with an increase to the periodicity of clock gene oscillations.
XAV939 and the CDK inhibitors extend the clock period in chick leading
to formation of fewer somites
To verify the extent to which the period had been extended in the presence of each of the reagents,
we performed a time course of the fix and culture assay. We determined the time needed for one full
oscillation by extending the time in culture for the cultured half until the expression profiles matched
in the two explants, with an extra somite having formed in the cultured explant. Untreated control
pairs completed one full oscillation and made an extra somite in 90 min whereas exposure to the
reagents resulted in an oscillation period of approximately 120 min (n = 8 for each inhibitor and for
DMSO; Figure 2—figure supplement 3E-J).
A prediction of the clock and wave-front model of somitogenesis is that a longer clock period will
result, assuming a constant wave-front speed, in the formation of fewer, larger somites in a given time.
Hence we analysed somite number in drug-treated explants cultured for an extended period of 6 hr
and found that fewer somites formed in the presence of Roscovitine (n = 9, mean number = 2.11),
DRB (n = 9, mean number = 1.94), PHA-767491 (n = 10, mean number = 2.5) and XAV939 (n = 7, mean
number = 3.14) compared to DMSO controls (n = 15, mean number = 4.25). Additionally, using the fix
and culture assay to confirm that the clock is still operating under treatment conditions, we observed
that Lfng expression is still dynamic after the 6 hr culture period (Figure 5D–H; n = 5/5 for each
Table 1. Summary table of densitometry quantifications for cNICD and mNICD in inhibitor assays
Treatment N
Mean adjusted relative fold
change of cNICD protein
± standard error
of the mean Statistical test p-value
XAV939 9 3.078 ±0.776 One-sample T-test 0.0280*
XAV939 (no CHX) 5 2.491 ±0.480 One-sample T-test 0.0361*
Roscovitine 10 1.94 ±0.255 One-sample Signed
Rank test
0.002*
Roscovitine
(no CHX)
7 1.594 ±0.146 One-sample T-test 0.00653*
DRB 8 2.557 ±0.702 One-sample Signed
Rank test
0.008*
DRB (no CHX) 6 1.369 ±0.081 One-sample T-test 0.00601*
Cyclopamine 2 1.263 ±0.106 One-sample T-test 0.244
PHA767491 2 3.479 ±0.451 One-sample T-test 0.115
MLN4924 3 8.831 ±2.734 One-sample T-test 0.103
Treatment N
Mean adjusted relative fold
change of mNICD protein
± Standard error
of the mean Statistical test p-value
XAV939 8 2.221 ±0.396 One-sample signed rank
test
0.008*
*demarcates a statistically significant difference.
Densitometry was performed on Western Blots and the fold change of cNICD or mNICD in the + inhibitor treated
sample relative to the corresponding DMSO control was adjusted to the relative change in the tubulin loading
control. The given statistical test was used to compare the average value for each assay to a fixed fold-change
value = 1 (i.e. no change) and a p-value obtained.
DOI: 10.7554/eLife.05842.011
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Figure 5. Length of newly formed somites are increased following long-term treatment with inhibitors. (A–C): Graphs showing log base 2 (fold) changes in
2 consecutive somite length ratios between the average somite lengths for the first (+1), second (+2), and third (+3) formed somites following treatment
initiation in the presence of DMSO, XAV939, Roscovitine, PHA767491 or DRB. T-tests were performed to test the null hypothesis that the mean somite
length ratio is the same as in DMSO controls. The null hypothesis was rejected in the starred cases (p < 0.005) with the following p values XAV = 0.0211;
Rosc = 0.0002; Pha = 0.0001; DRB = 0.0007 (D–H) Bissected chick caudal explant pairs subjected to the fix and culture assay after 6 hr treatment in the
presence of DMSO, XAV939, Roscovitine, PHA767491 or DRB. In each case the cultured side showed cLfng expression had advanced. (I–M) In situ
hybridisation of cTbx6 on whole embryos following 6 hr treatment in the presence of either DMSO, XAV939, Roscovitine, PHA767491 or DRB. Asterix =
newly formed somite(s) during culture, line = length of most recently formed somite, scale bar = 100 μm. (N–R) High magnification image of the samples in
(I–M). XAV939 treated embryos do not form as clearly defined boundaries as the other inhibitor treated embryos. (F) = following cycle.
DOI: 10.7554/eLife.05842.012
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reagent and for DMSO). Moreover, once the somites from the determined region of the PSM had
segmented we observed a significant stepwise increase in somite size along the anteroposterior axis
in the embryos cultured in the presence of XAV939, Roscovitine, PHA-767491 or DRB as compared to
DMSO control treated embryos (Figure 5A–C,I–R). Taken together, these data demonstrate that
XAV939, Roscovitine, PHA-767491 and DRB treatments all result in an extension of the clock period
and the formation of fewer, larger somites.
Exposure to XAV939, and the CDK inhibitors increases the half-life of
cNICD in the PSM
Given the delays inherent to Notch and Delta-like1 (DLL1) trafficking and their intercellular interaction,
it is possible that new NICD could be produced even in the presence of CHX, based on signalling
through receptors that were made prior to the initiation of CHX treatment. Thus, if XAV939,
Roscovitine or DRB increased the production of DLL1 or Notch1, the observed increase in NICD might
be secondary to increased signalling, rather than a result of changes in protein turnover. To address
this possibility, we replaced the 1h CHX treatment with a 1h LY411575 treatment to specifically block
production of new NICD, repeated the assay and measured levels of cNICD by Western Blot analysis.
Thus, one pool of PSMs was cultured for 3 hr in DMSO and the contralateral halves were cultured in
XAV939, Roscovitine or DRB. Both pools were then cultured for an hour in the presence of LY411575
before Western Blot analysis (Figure 4F). Remarkably, we observed that the level of cNICD protein
was again increased in the presence of XAV939 (Figure 4F, lane 4), Roscovitine (Figure 4F, lane 6) and
DRB (Figure 4F, lane 8) compared to the corresponding DMSO control pools (Figure 4F, lanes 3, 5, 7)
where NICD levels were severely diminished due to endogenous NICD degradation plus exposure
to LY411575 for an hour. As a control, explants cultured in explant media for 3h followed by 1h
LY411575 showed severe depletion of NICD compared to the corresponding DMSO pool of
contralateral halves (Figure 4F, lanes 1, 2). These data demonstrate that the higher levels of
cNICD observed following exposure to the inhibitors is not due to increased production of NICD.
In order to test the hypothesis that the observed increased level of NICD following inhibitor
treatment is due to modification of the half-life of NICD, we sought to quantify the half-life of
endogenous cNICD in the PSM. Pools of 9 explants from corresponding embryos were prepared as
above but cultured in the presence or absence of a given inhibitor. Following an initial 30 min exposure
to cycloheximide in both pools to inhibit new protein synthesis, the decay of cNICD protein was
monitored as follows: in one pool protein lysate was immediately prepared whilst in the other, culture
for an additional 30–60 min was performed before lysate was prepared (Figure 6—figure
supplement 1 and data not shown). Thus, the temporal decay of cNICD was quantified (see
Figure 6A). Notably the measured profiles are of the form predicted by Equation (4).
From these data we infer the NICD half-life and find that it takes the value 11.87 (+/− 4.97)
minutes in untreated control embryos (Figure 6A; n = 5). Strikingly, in the DRB, Roscovitine and
PHA-767491 treated explants, the half-life of cNICD protein is 29.59 (+/− 9.29), 22.01 (+/− 7.04) min,
and 36.41 (+/− 8.88) min, respectively (Figure 6A,B; n = 4 for each inhibitor). These data show that
DRB, Roscovitine and PHA-767491 treatments all significantly increase the half-life of cNICD protein
in the chick PSM. Thus, the data support the model prediction that an increased NICD half-life
results in a longer clock period.
Inhibition of SCF (SKP1- CUL1-F-box protein) E3 ubiquitin ligase
complexes results in delayed clock oscillations and higher levels of NICD
Whilst the measurements of NICD half-life are consistent with the model prediction that increased
NICD half-life will result in longer period oscillations and increased levels of NICD, we reasoned that if
NICD half-life is controlling the clock period, we ought to be able to increase the clock period by
targeting NICD turnover.
NICD stability is known to be regulated by the Skp, Cullin, F-boxSel10/FBXW7 (SCF Sel10/FBXW7) E3
ubiquitin ligase complex (Gupta-Rossi et al., 2001). We tested whether turnover of NICD within
the PSM affects the clock pace by repeating the half-embryo assay in the presence or absence of
MLN4924 which inactivates SCF E3 ubiquitin ligase complexes by suppressing neddylation of Cullin-1
(Soucy et al., 2009). As a control, we analysed levels of phosphorylated β-catenin which is also targeted
for ubiquitination and degradation by the SCF E3 ubiquitin ligase complex. As expected, exposure of
PSM explants to 1 μM MLN4924 led to increased levels of phosphorylated β-catenin (Figure 6D).
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Figure 6. cNICD half-life in the PSM is increased after exposure to Roscovitine, DRB and PHA-767491. (A): Endogenous cNICD levels analysed by Western
Blot (after normalisation to alpha tubulin loading control) in PSM explants cultured initially in the presence of each reagent for 3 hr and subsequently in
the presence of inhibitor plus cycloheximide for an additional 30 min before the time-course. Panels show log transformation on repeated data. The half
life is proportional to the inverse of the inferred slope (Equation [4]). (B) Bar chart showing the half-life of cNICD in each condition. Asterix represents
statistically significant differences p < 0.05. (C) Left Panel: Treatment in the presence (+) or absence (−) of MLN4924 for 3 hr reveals that the inhibitor
treated explant has lagging expression of cLfng compared to the control contralateral explant. Right panel: After 3 hr in the presence of MLN4924
one PSM explant was fixed while the other was treated for another 45 min, showing cLfng expression is still dynamic in the presence of this inhibitor.
(D) Following the assay described in Figure 4, levels of cNICD, normalised to levels of alpha tubulin, in the chick PSM pools are highly increased in the
presence of MLN4924. Western Blot analysis of pooled PSM lysates from half PSM explants treated ‘+’ or ‘−’ MLN4924 reveals levels of phosphorylated
β-catenin are increased in the chick PSM after 3 hr treatment with MLN4924.
DOI: 10.7554/eLife.05842.013
The following figure supplement is available for figure 6:
Figure supplement 1. Roscovitine, PHA-767491 and DRB treatment increases the level of cNICD in the chick PSM.
DOI: 10.7554/eLife.05842.014
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Notably, exposure of PSM explants to 1 μM MLN4924 caused a delay in the pace of Lfng dynamic
expression across the PSM (Figure 6C; n = 16) and increased levels of cNICD (Figure 6D; n = 3;
Table 1). The fix and culture assay confirmed that cLfng expression was still oscillatory in the PSM at this
concentration (Figure 6C; n = 16). Exposure to higher concentrations of MLN4924 (10–100 μM)
resulted in progressively greater increases in the level of cNICD but abolished dynamic Lfng
expression across the PSM (data not shown). Notably, the mathematical model predicts that
oscillations are only supported within a limited range of NICD (and Hes7) half-lives (See Figure 1).
These data support the central thesis provided in this paper: a balance between positive and
negative regulators is necessary for oscillations of the somitogenesis clock.
Reducing NICD production rescues the phase pattern changes and
increased level of cNICD in the PSM caused by exposure to XAV939, and
the CDK inhibitors
Taken together, the data presented thus far support the hypothesis that increasing the half-life of
NICD elevates levels of NICD and lengthens the period of oscillations. In order to directly address the
causality between increased NICD stability and the change in pace of oscillations, we attempted to
rescue the effect of the inhibitors by modifying NICD production in the PSM.
We performed a titration curve with the gamma secretase inhibitor LY411575 to reduce but not
remove NICD production. PSM pools were cultured for 3 hr in DMSO and their contralateral halves
cultured in different concentrations of LY411575. In the presence of 5 nM LY411575, cNICD levels
decreased significantly compared to the corresponding DMSO pool (Figure 7A, lanes 1, 2), while in
the presence of 1 nM or 0.1 nM LY411575, the levels of cNICD protein were similar to control DMSO
treated contralateral PSMs (Figure 7B, lanes 1, 2, Figure 7C, lanes 1, 2). Hence, pools of PSMs were
cultured for 3 hr in DMSO and the contralateral halves cultured in 10 μM Roscovitine together with 5
nM, 1 nM or 0.1 nM LY411575 prior to Western Blot analysis. The higher levels of NICD usually seen in
the presence of Roscovitine alone (Figure 7D) are rescued by 1 nM LY411575 such that they resemble
the levels of NICD in the corresponding DMSO pool (Figure 7B lanes 3, 4). These findings concur with
the predictions clearly proposed by our model (Figure 1H). In contrast, 10 μM Roscovitine together
with 5 nM LY411575 showed severely depleted levels of cNICD compared to the corresponding
DMSO pool (Figure 7A lanes 3, 4), resembling the effect of 5 nM LY411575 alone (compared to
Figure 7A, lanes 1, 2). 10uM Roscovitine together with 0.1 nM LY411575 showed increased levels of
cNICD compared to the corresponding DMSO pool, resembling the effect of 10 μM Roscovitine alone
(Figure 7C, lanes 3, 4, compared to Figure 7D).
We repeated these experiments and analysed the effect upon the mRNA expression of the clock
gene cLfng. 5 nM LY411575 severely reduced cLfng expression in the PSM (Figure 8A; n = 4/4)
whereas cLfng appeared largely unaffected in the presence of 1 nM or 0.1 nM LY411575, compared to
the control explant (Figure 8B,C; n = 22/25; n = 11/13, respectively). We then assessed whether we
Figure 7. Exposure to 1 nM LY411575 rescues the increased levels of cNICD caused by 10 μM Roscovitine.
Endogenous cNICD levels analysed by Western Blot (after normalisation to alpha tubulin loading control) in PSM
explant pools cultured for 3 hr in the presence (+) or absence (−) of (A) 5 nM LY411575 (lane 1,2); 10 μM Roscovitine
together with 5 nM LY411575 (lane 3,4) or (B) 1 nM LY411575 (lane 1,2); 10 μM Roscovitine together with 1 nM
LY411575 (lane 3,4) or (C) 0.1 nM LY411575 (lane 1,2); 10 μM Roscovitine together with 0.1 nM LY411575 (lane 3,4) (D)
or 10 μM Roscovitine alone.
DOI: 10.7554/eLife.05842.016
Wiedermann et al. eLife 2015;4:e05842. DOI: 10.7554/eLife.05842 15 of 28
Research article Computational and systems biology | Developmental biology and stem cells
Figure 8. Exposure to 1 nM LY411575 rescues the delay in clock gene oscillations caused by Roscovitine, DRB and
XAV939. Bissected chick or mouse caudal explant pairs treated ‘−’ or ‘+’ inhibitor and then analysed by insitu
hybridisation for LfngmRNA expression: (A–C) Treatment of chick PSM explants in the presence (+) or absence (−) of
5 nM LY411575 (A), 1 nM LY411575 (B), 0.1 nM LY411575 (C) for 3 hr reveals that 5 nM LY411575 severely
downregulates cLfng expression whereas 1 nM and 0.1 nM do not appear to change levels or domain of cLfng
Figure 8. continued on next page
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could rescue the changes in phase patterns brought about by Roscovitine, DRB or XAV939 by
reducing NICD production through exposure to 1 nM or 0.1 nM LY411575. Strikingly, we observed
a rescue of the phase pattern in a significant number of explants cultured in the presence of
Roscovitine, DRB or XAV939 together with 1 nM LY411575 (Figure 8G–I; n = 15/39, n = 8/20, n = 6/15,
respectively) compared to explants cultured in the presence of Roscovitine, DRB or XAV939 alone
which show a delay to the phase pattern (Figure 8D–F; n = 14/15, n = 9/10, n = 7/8, respectively).
Explants cultured in the presence of Roscovitine or XAV939 together with 0.1 nM LY411575 did not
rescue the delay caused by these inhibitors (Figure 8—figure supplement 1 and data not shown;
n = 0/9; n = 0/4).
These very striking data showing a rescue of both NICD levels and the delay to the clock
oscillations provide strong evidence that increased half-life and higher levels of NICD brought about
by Roscovitine, DRB or XAV939 underlie the delay to clock gene oscillations observed on exposure to
the inhibitors (Figure 9).
Discussion
Mathematical models that invoke the mechanism of delayed negative feedback have successfully
explained numerous experimental observations of the somitogenesis clock (e.g., Lewis, 2003; Monk,
2003; Hirata et al., 2004, Ay et al., 2013; Hanisch et al., 2013). These models are an excellent
example of how a relatively simple mathematical framework can provide insight into the behaviour
of a multi-component, multi-scale, nonlinear biological system. An elegant prediction of the models is
that the period of the somitogenesis clock can be approximated as a sum of the constituent delays
and the half-lives of negative regulators. However, whilst numerous studies have shown that genetic
modification of clock components can modify the clock period, relatively little work has been
published on whether half-lives of clock proteins have the predicted effect. Moreover, the models
neglect the potential role of positive regulators of clock gene expression. In this study we combine
experimental manipulation and mathematical modelling to begin to explore these issues.
In order to investigate the role of positive regulators of the somitogenesis clock, we modified
previous frameworks to account for the role of NICD in the somitogenesis clock. In the model, NICD
and the inhibitory clock protein compete to activate and repress the transcription of a clock gene,
respectively. Notably, the release of NICD is a multi-cellular phenomenon involving the periodic and
coordinated expression of cell surface proteins (Bone et al., 2014). In order to avoid describing
each of the constituent components, here we consider a model of a single cell oscillator and assume
that NICD is released periodically in a manner that is coupled to the transcription of other clock
genes (Bone et al., 2014). This formalism allows us to avoid explicitly modelling the temporal
dynamics of Delta and Notch across cell populations and focus solely on investigating the role of the
half-life of the positive regulator. The predicted outcome of the model is that increasing the half-life
of NICD elevates levels of NICD and lengthens the period of oscillations in addition to increasing
levels of the inhibitory clock protein. These effects can be rescued by decreasing the production
rate of NICD.
In order to explore whether these predictions can be validated experimentally, we have further
explored an intriguing phenotype whereby the application of a diverse range of small molecule
inhibitors results in a clear, robust delay in the pace of Lfng oscillations across the chick and mouse
PSM. We find that for each of the small molecule inhibitor treatments, the levels of the positive
Figure 8. Continued
expression. (D–F): Treatment of chick PSM explants in the presence (+) or absence (−) of Roscovitine (D), DRB (E) or
XAV939 (F) for 3 hr reveals that ‘+’ explants have lagging expression of cLfng, with one less somite formed than the
‘−’ explants. (G–I): Treatment of chick PSM explants in the presence (+) or absence (−) of 1 nM LY411575 together
with Roscovitine (G), DRB (H) or XAV939 (I) for 3 hr reveals that 1 nM LY411575 rescues the delay in clock gene oscillations
caused by these three inhibitors such that the cLfng expression domains in the ‘−’ and ‘+’ explants are very similar. The red
arrowheads identify the somites formed during the in vitro culture period of the assay. (P) = previous cycle.
DOI: 10.7554/eLife.05842.017
The following figure supplement is available for figure 8:
Figure supplement 1. 0.1 nM LY411575 does not rescue the delay in oscillation caused by Roscovitine.
DOI: 10.7554/eLife.05842.018
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Figure 9. A schematic illustration depicting how modification of NICD stability may cause a delay to the period of
the oscillations. (A) Schematic showing the competition between molecules of Hes7 and NICD for binding to the
promoter of a clock gene. Exposure to Roscovitine, XAV939 or DRB causes increased stability and levels of NICD
and thus NICD occupies the promoter for longer than in the wild-type situation, thereby prolonging the oscillation
period. Exposure to 1 nM LY411575 together with Roscovitine, XAV939 or DRB reduces the level of NICD production
offsetting the increased stability which rescues the delay. t1 = delay due to transcription of Hes7 and Notch; t2 = the
Figure 9. continued on next page
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regulator, NICD, are elevated and NICD half-life is increased. When interpreted within the framework
of the proposed model, these data support the hypothesis that treatment with the small molecule
inhibitors results in an increased half-life of the positive regulator NICD, which elevates the levels of
NICD, delays the clock, and results in the formation of fewer larger somites. In contrast, when
interpreted within the framework of the proposed model, the data do not support the hypothesis, for
instance: that the drug treatments solely modify the half-lives of negative regulators of the
somitogenesis clock, such as Hes7. We also demonstrate experimentally, in agreement with model
predictions, that both the delay in the pace of Lfng oscillations across the PSM and the elevated levels
of the positive regulator, NICD, resulting from exposure to the small molecule treatments can be
rescued by decreasing NICD production.
In this study we observe delays in the PSM phase pattern in the presence of small molecule
inhibitors that are rescued by Delta-Notch signalling inhibitors. From these observations we infer
that the autonomous frequency of individual oscillations is perturbed as a result of increased NICD
stability. Nevertheless, it is also possible that the effect of increasing the NICD half-life is to alter
tissue scale properties of the frequency gradient profile (e.g., increasing its rostro-caudal velocity or
steepness would result in a greater proportion of cells in the PSM experiencing lower frequencies
and thus observations of delayed phase patterns). Regardless of this detail, the premise of this study
remains intact: positive as well as negative regulators of the somitogenesis clock can regulate its
period.
We note that the inclusion of both positive and negative feedback into the somitogenesis clock
model introduces the possibility of interesting nonlinear phenomena that may have relevance to the
somitogenesis clock. For instance, Tsai et al. have shown that the inclusion of positive and negative
feedback loops can result in the attainment of a wide frequency range over a small range in amplitudes
(Tsai et al., 2008). This point is potentially relevant in the context of somitogenesis, where a frequency
gradient is thought to underlie the striking phase waves that traverse the rostro-caudal axis.
Wnt inhibition increases levels and half-life of cNICD and extends the
period of the clock
Previous reports have suggested that inhibition of Shh signalling slows the segmentation clock in
the chick PSM (Resende et al., 2010). In this study, we clearly show that, in our hands, inhibiting
the Shh pathway does not affect clock pace or the level of cNICD in the chick PSM within the
timeframe of our assay. A possible reason for this discrepancy with Resende et al. is that we
culture explant pairs for 3 hr whereas they observed delays to somite formation, in the absence of
Shh signalling, only after 7.5 hr culture and alterations to clock gene expression after 4.5 hr
culture. One possible explanation for the later arising effects they observe on the pace of the clock
and somite formation is that they that are indirect, secondary effects arising from Shh inhibition.
In contrast, we report Wnt inhibition, within a 3 hr time frame, elicited by exposure to XAV939,
increases the half-life of NICD in the chick and mouse PSM, leading to elevated NICD levels and
a clear and robust prolonged period of clock gene oscillations and somite formation. Intriguingly,
Gonzalez et al. previously reported exposure of mouse PSM explants to LiCl, which acts to inhibit
GSK3B, lengthens the period of Hes7 oscillations in the mouse PSM. However, the authors report
this effect may rather be via LiCl activation of the MapK pathway which is important for Hes
expression in the PSM (Gonzalez et al., 2013), since more specific approaches to elevate Wnt
signalling have been shown not to change the endogenous period of the segmentation clock
(Aulehla et al., 2008; Gibb et al., 2009). Moreover, Gonzalez et al. found the Wnt inhibitor CKI-7
delayed clock gene oscillations in the mouse PSM, in line with our own observations (Gibb et al.,
2009; Gonzalez et al., 2013).
Figure 9. Continued
delay due to translation of Hes7; t3 = delay due to translation of Notch and subsequent ligand dependent
production of NICD. (B) Graphical model depicting how modifying the stability of NICD may cause a delay to the
period of the oscillations by delaying the time-point at which proportional levels of NICD and Hes7 allow switching
of promoter occupancy of these two factors.
DOI: 10.7554/eLife.05842.015
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CDK inhibitors roscovitine, DRB and PHA-767491 regulate the period of
clock gene oscillations
We demonstrate that three CDK inhibitors, Roscovitine, DRB and PHA-767491, also increase the
half-life of cNICD and delay the pace of Lfng oscillations at concentrations that have no significant
effect on cell proliferation. At higher concentrations of inhibitors that did affect proliferation, the
oscillations of Lfng expression were abolished. Importantly, these data separate the effects of
the inhibitors on the segmentation clock from those on the cell cycle. This finding is consistent with
the ‘clock and wavefront’ model of somitogenesis, rather than a cell cycle based model (Cooke and
Zeeman, 1976; Stern et al., 1988).
Tight control of the half-life of NICD, a positive regulator of oscillatory
clock gene expression, appears key to regulating the clock period
A striking finding is the fact that these very different pharmacological reagents share distinctive
phenotypic outputs: increased levels and half-life of NICD and extended period of the clock gene
oscillations. This raises the compelling prospect that these effects are causally linked. Recent data
showing that Notch1 protein is dynamically and periodically expressed in the chick and mouse
PSM in a Notch dependent fashion (Bone et al., 2014) demonstrate that Notch1/NICD is itself
part of a positive feedback loop. We experimentally validate the prediction that under conditions
where half-life of NICD is increased, the period of the clock is extended. Our data thus expand
upon previous models by highlighting the necessity for an added level of regulation, namely the
strict regulation of the half-life for the positive input signal, NICD. Hence, it appears equally
important to balance levels of both positive and negative input to correctly regulate the
periodicity of clock gene oscillations. This result is similar to observations made in Nrarp-null
mice, which display increased NICD levels in the PSM and a decrease in somite and vertebral
body number although the pace of clock gene oscillations and somite size was not assessed (Kim
et al., 2011).
Our data with the neddylation inhibitor MLN4924 further substantiate the hypothesis that
extended NICD half-life is causally linked to the extended clock period, given that this reagent, which
acts via a completely distinct molecular mechanism, nevertheless leads to the same phenotypic output
as the Wnt and CDK inhibitors. Thus, in addition to the expected higher levels of NICD in the PSM of
MLN4924 treated explants, we saw a corresponding increase in the period of Lfng oscillations, as seen
for XAV939, Roscovitine, DRB and PHA-767491 treated explants. In addition to elevating levels of
NICD, exposure to MLN4924 elevates levels of phosphorylated β-catenin within PSM lysates. Since we
show that Wnt inhibition can lead to elevated NICD levels and a delay to clock oscillations, this raises
the possibility that the effects of MLN4924 are mediated via Wnt inhibition rather than directly via
NICD turnover. However, we propose this is unlikely since in the absence of a degradation pathway
the elevated levels of phosphorylated β catenin may in fact continue to participate in target gene
transcription. Indeed, APC mutant lines which allow β catenin phosphorylation but are defective in
ubiquitination are oncogenic, consistent with the idea that phosphorylated β catenin can indeed
activate target genes (Yang et al., 2006). Thus, we propose that the extended period of the clock
seen following exposure to MLN4924 is due to the elevated levels of NICD brought about via
inhibition of NICD degradation. Exposure to higher concentrations of this inhibitor leads to
correspondingly higher levels of NICD in PSM explants and this accompanies a loss of dynamic Lfng
expression. A similar correlation is seen in PSM explants exposed to increasing concentrations of
Roscovitine, DRB, PHA-767491. It has previously been shown that overexpression or complete loss of
Notch signalling abolishes clock gene oscillations and causes severe segmentation defects (Niwa
et al., 2007; Feller et al., 2008; Ferjentsik et al., 2009). These data, together with previous reports
investigating the effect of modulating protein levels of key clock components (Hirata et al., 2004; Kim
et al., 2011), indicate that there is a tolerance window for the degree of variance in levels of positive
and negative input which will still allow for oscillatory gene expression. These experimental findings are
consistent with the predictions of our model which also clearly predict that there is a window within
which variations in half-life of both Hes7 and NICD will allow for oscillations. Taken together, our
computational and experimental data show that slowing, as opposed to stopping, of the segmentation
clock gene oscillations may be brought about through transient and/or partial stabilisation of Notch
activity.
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The rescue of both phase pattern changes and NICD levels elicited by exposure to both low
concentrations of LY411575 together with Roscovitine, DRB or XAV939 provides compelling evidence
that increased half-life and higher levels of NICD brought about by these inhibitors underlies the delay
to clock gene oscillations (Figure 9).
Following exposure to Roscovitine, DRB, PHA-767491 and XAV939, the Western Blot data reveal an
additional band for NICD at a slightly lower molecular weight in some of the inhibitor treated samples
as compared to the control treated samples. This observation is characteristic of an increase in
abundance of a variant of a protein which lacks small post-translational modifications such as
phosphate groups. This shift may therefore represent the loss of phosphorylation marks which
have been shown to be important for NICD regulation and degradation (Fryer et al., 2004; Jin
et al., 2009). These data support the idea that post translational modification events may
regulate the stability of NICD that could then directly affect the pace of the segmentation clock.
XAV939, Roscovitine, DRB and PHA-767491 may directly affect NICD
half-life through post translational modification of NICD
As alluded to above, post translational modifications may underlie the effects of the 4 reagents that
each modulate NICD half-life and clock period. We demonstrate that XAV939 treatment elevates
levels of GSK3B-mediated phosphorylated β catenin in the PSM and it is possible that it might
equally facilitate GSK3B mediated phosphorylation of NICD which has previously been reported to
affect NICD stability (Espinosa et al., 2003; Jin et al., 2009). It is noteworthy that the effect of this
phosphorylation event on NICD stability is likely to be context dependent since different groups
have reported this modification can increase or decrease NICD stability and it is not known if any of
these interactions occur in the PSM (Foltz et al., 2002; Espinosa et al., 2003; Jin et al., 2009).
Similarly, it is possible that the CDK inhibitors modulate CDK-mediated phosphorylation of NICD
which has also been reported to affect NICD stability (Fryer et al., 2004). Interestingly, exposure to
specific CDK7, CDK8 or CDK9 inhibitors did not yield the delayed oscillation phenotype or increased
levels of NICD and half-life of NICD in the chick PSM (data not shown). These data are somewhat
surprising given that there are published reports describing a role for CDK8 in phosphorylating and
thereby destabilising NICD. Indeed, CDK8-mediated phosphorylation in the PEST domain of NICD is
required to target this protein for ubiquitination and subsequent degradation by the E3 ligase FBW7
(Fryer et al., 2004). Whilst it is possible that this mode of regulation of NICD stability by this specific
CDK does not occur in the PSM, we acknowledge that it is also possible that the effect on pace and
cNICD stability are only made apparent when inhibiting a combination of these activities as seen with
Roscovitine, DRB and PHA-76749. It is important to note that an alternative explanation for the lack of
effect of specific CDK7, CDK8, or CDK9 inhibitors is that the effect of Roscovitine, DRB and PHA-
767491 may be through inhibition of a different set of kinases. The precise identification of the kinase(s)
involved in destabilising cNICD will require further investigation.
XAV939, roscovitine, DRB and PHA-767491 may indirectly affect
NICD half-life and the clock period through transcriptional regulation
of NICD-stability regulators
It is also formally possible that the common outcome of exposure to these four reagents to influence
the pace of the clock involves regulation at the transcriptional level. Roscovitine is known to have
highest efficacy against CDK2/CyclinE, CDK5, CDK7/CyclinH and CDK9/CyclinT (McLue et al., 2002)
whereas DRB and PHA-767491 reduce the kinase activities of CDK7/CyclinH and CDK9/CyclinT
towards Serine 2 and Serine 5 on the C-terminal domain (CTD) of RNA pol II. Exposure to DRB,
Roscovitine, or PHA-767491 leads to a reduction in Ser5 RNA pol II phosphorylation (Figure 2—figure
supplement 1B) which is required to promote initiation of transcription as RNA pol II moves away
from the gene promoter (Kormarnitsky et al., 2000) but it is also associated with ‘poised’ genes
bound by both Ser5 phosphorylated RNA pol II and Polycomb repressor complexes (Brookes and
Pombo, 2012). Thus, one possibility is that reduced Ser5 phosphorylation of RNA pol II may leave
some ‘poised’ genes in the PSM in a more repressed state. Importantly, certain gene transcripts are
more susceptible to DRB treatment than others (Zandomeni and Weinmann, 1984; Chodosh et al.,
1989; Wada et al., 1998) and indeed we find not all gene transcripts in the PSM are down-regulated
by these inhibitors (e.g., cLfng and cHairy2 expression is delayed in the PSM but not down-regulated).
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Thus, the effects of these inhibitors may be to modify certain ‘poised’ genes to a more repressed state
that specifically include genes encoding factors required for destabilising NICD.
Given that XAV939 elicits the same phenotypic output as exposure to the CDK inhibitors it is
conceivable that all four reagents affect the transcription of some common genes; some involved in
regulating the clock while others not; indeed we identified one gene commonly affected by all 4
reagents namely Gli1 (known to be regulated by Wnt signalling in the neural tissue and somites
(Munsterberg et al., 1995), Figure 2—figure supplement 1E–G). For this particular gene we show it
is unlikely to be involved in clock regulation (Figure 3). However, a transcriptomic analysis of common
target genes would allow this possibility to be fully explored to identify genes co-regulated by these
reagents which potentially encode regulators of NICD stability in the PSM.
Finally, a recent report has beautifully demonstrated that in zebrafish embryos the rate of tissue
shortening, in addition to the periodicity of clock gene oscillations, is important in determining
the periodicity of segmentation (Soroldoni et al., 2014). Further analyses are required to investigate
if this is a conserved feature in all vertebrate species. That analysis notwithstanding, our data
nevertheless clearly show that the pace of the segmentation clock itself has a strong influence upon
the pace of somite formation since significantly fewer somites are formed within a given time-frame
when the pace of clock gene oscillations and NICD stability are affected. In conclusion, our data
suggest that the stability and turnover of NICD is inextricably linked to the regulation of the pace of
clock gene expression across the PSM.
Materials and methods
Experimental Procedures
Chick culture
Fertilized chick (Gallus gallus) embryos from Winter Farm, Cambridge, UK, were incubated for
approximately 40 hr at 38˚C 5% CO2 to yield embryos between Hamburger Hamilton (HH) stages 10–12
as judged by somite number and morphology. Explants were prepared as previously described
(Palmeirim et al., 1997). In brief, for the half-embryo assay: the caudal end of the chicken embryo is
isolated to contain the most caudal somite pairs and the tail tissues. The isolated tail is then bisected
down the midline along the neural tube to produce two identical left and right half-PSM explants which
allows an internal control from the same embryo with which to compare the oscillation phase of cLfng
expression by in situ hybridisation, following culturing of the two halves in various culture conditions. The
following small molecule inhibitors were typically used at the given concentrations and dissolved in
Dimethyl sulfoxide (DMSO) unless otherwise stated: 150 nM LY411575 unless otherwise stated
(generated in house, University of Dundee; Ferjentsik et al., 2009; Bone et al., 2014), 1 μM MLN4924
(generated in house, University of Dundee); 20 μM Cycloheximide (Tocris Bioscience; dissolved in
ethanol); 100 μM XAV939 (Tocris Bioscience); 25–50 μM Cyclopamine (Calbiochem); 10 μM Roscovitine
(Calbiochem); 10 μM 5,6-Dichloro-1-beta-D-ribofuranosylbenzimidazole (DRB) (Sigma, United
Kingdom); 1 μM PHA-767491 (kind gift from Nathanael Gray, HARVARD.EDU). Titration assays were
performed to establish the lowest concentration that abolishes expression of control target genes. For
Fix and culture: both half-PSM explants were treated with inhibitor but while one was removed from
culture after 3 hr (‘fix’), the other side was cultured for an additional 45 min (‘culture’) which corresponds
to half of the usual 90 min cycle for a complete oscillation of cLfng in the chicken PSM. Variations include
culturing the ‘culture’ side for ‘90’ or ‘120’ min to determine the length of an oscillation. For the Western
Blot analysis half-PSMs from 9 embryos were cultured in DMSO control vehicle and the corresponding 9
half-PSMs cultured in the presence of a small molecule inhibitor. Following 3 hr of culture, both pools
were treated with 20 μM Cycloheximide for an additional 30 min before protein lysates were prepared
simultaneously. For the half-life assay: half-PSMs from 9 embryos were pooled and both pools were
cultured in each of the reagents for 3 hr and following 30 min exposure to cycloheximide, the decay of
cNICD protein was monitored in the presence of these inhibitors by lysing PSM explants at different
time points. Experiments were conducted in strict adherence to the Animals (Scientific Procedures) Act
of 1986 and UK Home Office Codes of Practice for use of animals in scientific procedures.
In situ hybridisation
Whole-mount in situ hybridisations utilising exonic and intronic probes were performed as described
(Gibb et al., 2009).
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Phospho-HistoneH3 staining
Fixed PSM explant tissue was proteinase K (Roche) treated and fixed (4% formaldehyde in PBS, 2 mM
EGTA, 0.1% glutaraldehyde [Sigma]) prior to washing in PBST. Explants were then blocked in 2%
bovine serum albumin (BSA) in PBST for 2 hr at room temperature. Anti-phospho histone-H3 antibody
(Upstate) was then added at 10 μg/ml and the samples incubated at 4˚C overnight. Specimens were
then washed for 10 hr in a minimum of three changes of PBST before the Alexa-fluor488 conjugated
mouse anti-rabbit antibody (Invitrogen) was added at 2 μg/ml in PBST and left overnight at 4˚C.
Samples were then washed for 10 hr in PBST with a minimum of 3 changes of solution. Explants were
then mounted on SuperFrost microscope slides (VWR) using Hydromount (National Diagnostics) and
imaged using either a compound fluorescence microscope (Leica DM5000 B) or a Zeiss 710 confocal
microscope. Images were quantified using Volocity v6.0.1 imaging software (Perkin Elmer) and either
t-tests or Mann–Whitney tests performed using SigmaPlot v12.0 software.
NucView apoptosis staining
+/− treated explant pairs were cultured for 2 hr (chicken) or 3 hr (mouse) before the addition of 5 μM
NucView 488 Caspase-3 Assay Kit for live cells (Biotium) and cultured for an additional 1 hr. Samples
were then fixed for 1 hr at 4˚C in 4% formaldehyde/PBS. Samples were then washed into PBST and
explant pairs were mounted on superfrost slides (VWR) in Prolong Gold anitfade reagent (Molecular
Probes) for imaging on a Zeiss 710 confocal microscope. Quantification of NucView cell staining was
performed using Volocity v6.0.1 imaging software (Perkin Elmer) and statistical analyses done using
either t-tests or Mann–Whitney tests with Sigmaplot v12.0 software.
Generation of cNICD antibodies
The peptide VLVSRKRRREHGC (corresponding to residues 1792–1803 of the chicken NOTCH1
protein, with the addition of a C-terminal cysteine residue for coupling) was coupled separately with
Keyhole Limpet Hemocyanin (KLH) and BSA using m-maleimidobenzoyl-N-hydroxysuccinimide ester
(MBS) and dialysed into PBS. The affinity purification of the cNICD antibody was achieved by putting
the third bleed serum from the rabbit which had been immunised with the peptide on an affinity
column which had been previously prepared by coupling the cNICD peptide with vinylsulfone
activated sepharose. The purified antibody was then dialysed into PBS.
Western Blot analysis
Pooled samples of 9 Chick embryo half-PSM explants were prepared by pipetting treated tissue in 90 μl
mixture containing lysis buffer (50 mM Tris Hydrochloride pH7.5, 150 mM Sodium chloride [NaCl], 1 mM
ethylenediaminetetraacetic acid [EDTA], 1 mM ethylene glycol tetraacetic acid [EGTA], 10 mM Sodium
pyrophosphate, 10 mM Sodium glycerophosphate, 50 mM Sodium fluoride, 1 mM Sodium
orthovanadate, 0.3% 3-[{3-cholamidopropyl} dimethylammonio]-1-propanesulfonate [CHAPS], 1 mM
Benzamidine, 0.1% β-mercaptoEtOH, 0.1 mM phenylmethanesulfonylfluoride [PMSF]), supplemented
with 1x Sample Reducing Agent and 1x LDS Sample Buffer (Life Technologies). Samples were then
reduced at 95˚C for 5 min and allowed to cool briefly before loading 20 μl of each sample onto 4–12%
Bis–Tris acrylamide gels (Life Technologies). Gels were then Blotted using standard molecular techniques
and the resultant nitrocellulose membranes (Whatman) were blocked in 5% milk in TBS–0.1% Tween 20
(TBST). Membranes were treated overnight at 4˚C in one of the following antibodies diluted in 5% BSA in
TBST: 1:1000 rabbit anti-chick NICD (University of Dundee); 1:1000 rabbit anti-mouse NICD (Cell
Signalling); 1:1000 rabbit anti-phospho S33, S37, T41 β-catenin (Cell Signalling); 1:5000 rabbit anti-total
β-catenin (I. Nathke); 1:1000 rabbit-anti Fbw7 (Abcam); 1:1000 rabbit anti-mouse Hes7 (University of
Dundee, generated as Bessho et al., 2003); 1:200 rat-anti phospho S2 RNA pol II (Chromotek); 1:200
rat-anti phospho S5 RNA pol II (Chromotek); 1:200 rat-anti total RNA pol II (Chromotek); 1:5000 mouse
anti-α-tubulin (Abcam). Membranes were then incubated with the appropriate secondary antibody (HRP)
in 5% milk in TBST and standard ECL revelation (Pierce).
Statistical approach
It was hypothesized that half-life of NICD would alter as a function of the treatments applied.
Small samples and short time series limited the ability to develop a robust empirical model that
could be broadly applied; as such each half-life was developed on a per treatment basis with linear
modelling. Natural log transformations were performed on concentrations such that a slope and
intercept could be reasonably estimated. Those with significant slopes are reported in Figure 6.
Statistical analyses were conducted in R 3.2.0 (R Core Team, 2013).
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Mathematical model
We develop a minimal model of the somitogenesis clock with the goal of exploring the roles of both
negative and positive feedback of clock products on clock dynamics. The model has two dependent
variables: numbers of cytoplasmic clock protein, p(t), and NICD, n(t). Given that cytoplasmic clock
protein and NICD act as a transcriptional repressor and activator, respectively, we assume that the
rate of production of clock gene products is proportional to
f ðp;nÞ=

n
Kn

1+

p
Kp
2   ; (1)
where Kp is an IC50 constant and Kn is a constant that determines a scale for NICD activation. We note
that the competition between activation and repression of transcription by NICD and clock protein,
respectively, that is encapsulated by Equation (1) plays a key role in the model behaviour.
Assuming linear decay of cytoplasmic protein at rate k2, the rate of change of numbers of
cytoplasmic clock protein with respect to time is given by the delay differential equation
    dp
dt
= k1f ðpðt −T1Þ;nðt −T1ÞÞ− k2pðtÞ;   (2)
where the delay T1 represents the time that elapses between protein/NICD influencing transcriptional
activation and the effect on cytoplasmic protein levels (i.e. the sum of transcription, splicing, export
and translation delays).
Whilst it is well established that NICD undergoes pulsatile dynamics in the PSM, Notch1 and Dll1
undergo qualitatively similar behaviour and Notch is a target of Notch signalling (Bone et al., 2014).
The production of NICD within a given cell is therefore a multicellular process with multiple oscillatory
regulatory inputs. We capture the periodic production of NICD by making the simplifying assumption
that the production rate of NICD is the same as that of clock protein but with a longer delay, T2, to
account for the trafficking of Notch1 and Dll1 to the membrane and their transactivation. Assuming
that NICD decays at rate k4, we obtain
dn
dt
= k3f ðpðt −T2Þ;nðt −T2ÞÞ− k4nðtÞ: (3)
We use this model (Equations (1)-(3)) to investigate how the decay kinetics of both positive and
negative regulators of clock transcription can influence the oscillator period. Further model details can
be found in the Supplementary file 1.
Measuring the half-life of endogeneous NICD
In order to measure the half-life of endogeneous NICD, the following experimental protocol is
followed: 9 embryos are dissected along their midlines with contralateral halves placed in two pools
(A and B). The pools are initially cultured for 3 hr, either in the presence of a drug or control medium,
and then for 30 additional minutes in the presence of a translation inhibitor. The samples from pool A
are homogenised and the total amount of NICD in a given pool is quantified. Pool B is then cultured
for a further time τ (30, 40 or 60 min), homogenised and NICD is quantified.
Consider Pool A and let Ai(t) represent the amount of NICD in the i
th PSM at time t (where t=0
represents some arbitrarily chosen position in the periodic NICD cycle). The (experimentally
measurable) total amount of NICD in the whole of Pool A is given by
A= ∑
N
i
AiðtÞ;
where N is the number of samples in the pool. Similarly, the total amount of NICD in Pool B is given by
B= ∑
N
i
BiðtÞ:
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As the samples in Pools A and B are paired (contralateral halves), Bi(t)=Ai(t+τ), where τ is the
additional culture time for Pool B, hence
BðτÞ= ∑
N
i
Aiðt + τÞ:
Calculating the ratio of total amount of NICD in Pool B to that of Pool A, we define
FðτÞ=BðτÞ
A
:
As each of the nine tissue samples can be thought of as being random samples from some
underlying periodic NICD time series, A(t), the above sums can be thought of as representing a naive
Monte Carlo integration. Hence the experimentally calculated F(τ) is an approximation to
FðτÞ=
R T
0 Aðt + τÞdtR T
0 AðtÞdt
;
whereT represents the period of the oscillations. The question now is whether the half-life of NICD can
be inferred by experimentally measuring F(τ) at different values of τ.
In the case where A(t) is periodic, both integrals will tend to the same value and the measure
tends to one. In contrast, if production of NICD ceases, and NICD undergoes only linear decay,
A(t+τ)=A(t)e−βτ, where β is the NICD degradation constant. In this case,
FðτÞ=
R T
0 AðtÞe−βτdtR T
0 AðtÞdt
= e−βτ;
and the measure decays exponentially. Combining, if production stops at some time ts after the
experiment begins, we obtain the measure
FðτÞ=

1;   τ< ts
e−βðτ−tsÞ;     τ≥ ts:
Taking natural logs we obtain
lnðFðτÞÞ=

0;   τ< ts
−βðτ− tsÞ;   τ≥ ts:   (4)
Hence linear regression allows the determination of the decay constant β and the corresponding
half-life is calculated to be ln 2/β.
Whilst the above equation predicts the experimental measure in the case of a large number of
samples, it is notable that the effective finite sampling of the integrals could result in large
measured deviations from mean behaviour. In fact, noting that NICD dynamics are strongly
pulsatile, the above integrals will likely be dominated by the number of sampled NICD peaks in
a given pool.
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